Corporate Governance

Annual General Meeting

Financial year 2024-25

AGM Transcript

Voting Results

AGM Proceedings

Post-Dispatch Advertisement

AGM Notice 2025

AGM Notice

Pre Dispatch Advertisement

Financial year 2023-24

AGM 2024 Transcript

Voting Results

Post Dispatch Advertisement

AGM Notice 2024

AGM Notice

PRE DISPATCH ADVERTISMENT

Financial year 2022-23

Voting Results

Pre Dispatch Advertisement

Post Dispatch Advertisement

AGM Proceedings

AGM Notice

AGM 2023_Trancsript

Postal Ballot

Financial year 2024-25

Postal Ballot Results March 17, 2025

March 17, 2025

Newspaper Adv. for Postal Ballot Feb 12, 2025

Feb 12, 2025

Postal Ballot Notice February 04, 2025

Feb 04,2025

Postal Ballot Results December 28, 2024

Dec 28, 2024

Newspaper Adv for Postal Ballot Nov 27, 2024

Nov 27, 2024

Postal Ballot Notice November 14, 2024

Nov 14, 2024

Postal Ballot Results Jun 27, 2024

Jun 27, 2024

Newspaper Adv for Postal Ballot May 28, 2024

Postal Ballot Notice May 17, 2024

Financial year 2022-23

Postal Balot Newspaper Advertisement Dec 2022

Postal Ballot Notice Dec 2022

Postal Ballot Results Jan 2023

Shareholders` information

SEBI Circular for linking of SCORES Platform and ODR Portal

20 Sept 2023

Form – SH-14 - Cancellation or Variation of Nomination

Form - SH-13 and ISR-3 – Registration of Nomination and Declaration for Opting-out

Form ISR-4 - Request for issue of Duplicate Certificate and other Service Requests

Form - ISR-2 – Confirmation of Signature by the Banker

Form - ISR-1 - Request form for Registering PAN, Bank A/c ,KYC

SEBI Circular on Choice of Nomination

10 June 2024

SEBI Circular on Extension of Timelines for submission of PAN, Nomination and KYC details

SEBI Circular for norms of processing Investor’s Service Requests

November 17, 2023

SEBI Circular on Online Dispute Mechanism

July 31, 2023

SEBI Circular for Extension of timeline for submitting Choice of Nomination in Demat accounts

27 Dec, 2023

SEBI Master Circular for Online Resolution of Disputes

Dec. 28, 2023

Shareholders FAQ

No Data Found!

IPO Documents

GHL Final MOA AOA 28 January, 2023

B.36_Final Observation Letter_21.12.21

B.35_In Principle Approval_21.10.21 and 22.10.21

B.34_DD Certificate_29.09.2021

B.33_Triparty Agreement btw Co CDSl & Registrar_09.09.2021

B.32_Triparty Agreement btw Co NSDl & Registrar_09.04.2021

B.31_Consent of RM Marwah CA to Include their name in RHP as Expert

B.30_Consent of CA to Include their name in RHP as Expert with respect to Examnination Report _02.09.2022

B.29_ Consents

B.28_Engagement Letter of CRISIl_15.09.22

B.27_Consent for Assessment of Health Delivery Market_26.09.2022_CRSIL

B.26_Assessment of Health Delivery Market_26.09.2022_CRSIL

B.25_Special tax Benefit Report_14.10.2022

B.24_CA Examniation Report_02.09.22

B.23_Annual Report 19-20

B.22_ BR dated July 25, 2022 _Re-appoinment of Dr.NT as CMD and Chaiman-, Heart Institure and CCS

B.21_Resolutions for appoinmnet of Dr.NT as Chaiman-Heart Institute and CCS

b.20_Resolutions for appoinment of Dr.NT as CMD

B.19_Trademark Licence Agreement_25.11.2013

B.18_ Agreement_04.01.2022_Conversion of CCPS

B.17_ Waiver Amendment and Termination Agreement_14 09 2021 and WATA Extn Letter June 30 2022

B.16_Agreement dated 13.05.2017_ Dr. NT and SS

B.15_Undertaking_05.10.2015 RJ Corp

b.15_RJ Corp_ Investment Agreeement_Suppl Agreement and Undertaking

B.14_SHA _12.01.2015

B.13_SHA _29.10.2013

B.12_Scheme of amalgamation and merger of NTAHS with Co

B.10_Consent Letter of Investor Selling Shareholder_11.10.2021

B.11_Share Purchase Agreement_13.05.2017

B.9_BR_RHP Approval_22.10.2022

B.8_BR and Shareholders Approval for Modification in OFS

B.7_BR Approving Addendum to DRHP

B.6_BR Approving DRHP_29.09.2021

B.5_Shareholder Resolution_Authorising Offer_21.09.2021

B.4_BR_Authorising Offer_17.09.2021

B.3_Fresh COI dated 11.08.2021

B.2_COI_13.08.2004

B.1_CTC of MOA & AOA

Material Contracts For The Offer

A.7 Underwriting Agreement-November 9, 2022

A.6 Monitoring Agency Agreement

A.5 Share Escrow Agreement

A.4 Syndicate Agreement

A.3 Cash Escrow and Sponsor Bank Agreement

A.2 Registrar Agreement and Amendment Agreement

A.1 Offer Agreement and Amendment Agreement

Investor Contact

Registered Office:

Global Health Limited
CIN: L85110DL2004PLC128319
Medanta-Mediclinic E-18,
Defence Colony
New Delhi-110024
Ph No.011- 44114411

Corporate Office:

Medanta – The Medicity,
Sector-38, Gurugram,
122001, Haryana
Phno: 124-483-4060

For Investor Grievances

Mr. Rahul Ranjan, Compliance Officer
Medanta – The Medicity,
Sector-38, Gurugram,122001, Haryana
Tel: 124 483 4060;
Email: : compliance@medanta.org

Registrar & Share Transfer Agent

KFIN Technologies Limited
Selenium, Tower-B
Plot 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032
Telangana, India

Toll-Free/ Phone Number : 1800 309 4001

WhatsApp Number : (91) 910 009 4099

KFINTECH Corporate Website: https://www.kfintech.com

RTA Website : https://ris.kfintech.com

Investor Support Centre (DIY Link) https : https://ris.kfintech.com/clientservices/isc

SEBI Registration No. : INR000000221

Online Dispute Resolution Login link: https://smartodr.in/intermediary/login

Contact Details of Key Managerial Personnel Under Regulation 30(5) of SEBI LODR, 2015

S. No

Name & Designation

Email address

Contact Number

Dr. Naresh Trehan,

Chairman & Managing Director

compliance@medanta.org

Tel: +91 124 483 4060

Mr. Pankaj Sahni,

Group CEO & Director

compliance@medanta.org

Request Call Back